Literature DB >> 11006766

Population-based fecal occult blood screening for colon cancer: will the benefits outweigh the harm?

K G Marshall1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11006766      PMCID： PMC80462     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  22 in total

1.  Reprocessing of flexible gastrointestinal endoscopes. American Society for Gastrointestinal Endoscopy.

Authors: 
Journal:  Gastrointest Endosc       Date:  1996-05       Impact factor: 9.427

2.  Sigmoidoscopy and rectal biopsy: a survey of current UK practice.

Authors:  R J Robinson; M Stone; J F Mayberry
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-02       Impact factor: 2.566

Review 3.  Complications of colonoscopy and flexible sigmoidoscopy.

Authors:  J D Waye; O Kahn; M E Auerbach
Journal:  Gastrointest Endosc Clin N Am       Date:  1996-04

Review 4.  Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1996-07-15       Impact factor: 8.262

5.  Actual causes of death in the United States.

Authors:  J M McGinnis; W H Foege
Journal:  JAMA       Date:  1993-11-10       Impact factor: 56.272

6.  The last well person.

Authors:  C K Meador
Journal:  N Engl J Med       Date:  1994-02-10       Impact factor: 91.245

7.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

8.  Endoscopic and surgical complications of work-up in screening for colorectal cancer.

Authors:  J Kewenter; H Brevinge
Journal:  Dis Colon Rectum       Date:  1996-06       Impact factor: 4.585

Review 9.  Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1996-05-15       Impact factor: 8.262

10.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245
View more
  12 in total

1.  Prostate cancer screening: should family physicians discuss it with their patients?

Authors:  M Greiver
Journal:  Can Fam Physician       Date:  2000-12       Impact factor: 3.275

2.  Primary care--the hard parts.

Authors: 
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

3.  Colorectal cancer screening: you can't be positive about a negative result.

Authors:  J Hoey; E Wooltorton
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

4.  Screening for colorectal cancer.

Authors:  C J Wright
Journal:  CMAJ       Date:  2001-04-03       Impact factor: 8.262

5.  Screening for colorectal cancer.

Authors:  G Brock; V Gurekas
Journal:  CMAJ       Date:  2001-04-03       Impact factor: 8.262

6.  Screening for colorectal cancer.

Authors:  S Latosinsky
Journal:  CMAJ       Date:  2001-04-03       Impact factor: 8.262

7.  Considering colorectal screening.

Authors:  Bruce Brady
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

8.  Colorectal cancer screening: in your office now?

Authors:  Frederick Burge
Journal:  Can Fam Physician       Date:  2003-07       Impact factor: 3.275

9.  Screening and the family physician.

Authors:  Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

10.  CON: Hepatocellular Carcinoma Surveillance: In Need of Higher-Quality Data.

Authors:  Amit G Singal
Journal:  Am J Gastroenterol       Date:  2017-10-10       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.